Altamira Therapeutics Ltd (CYTO) Stock Split History

Altamira Therapeutics Ltd has split its stock 4 times since its initial public offering (IPO). The first stock split occurred on March 14, 2018 with the ratio of 1-for-10, meaning that for 10 shares of CYTO owned pre-split, shareholders then owned 1 share. 3 more splits have been implemented since then. The most recent stock split took place on December 13, 2023 on a 1-for-20 basis.

These splits have increased CYTO stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Altamira Therapeutics Ltd's total market capitalization.

For more detailed information of Altamira Therapeutics Ltd's stock splits, view the table below:

The answer will depend on the decisions of the company's managers and market volatility. Altamira Therapeutics Ltd has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when CYTO stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Altamira Therapeutics Ltd's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.